Deep knowledge on
small-molecule drugs and
the 90,000 global patents
covering them

Subscribe to Free Drug Patent Expiration Updates

Also available in a Drug Patent Expiration NewsletterRSS feed and on Drug Patent Expirations on TwitterTwitter

DrugPatentWatch Archives

You are currently viewing the 2000 archives
Click here to return to the current data set

DrugPatentWatch Ultimate Plan Preview

Profile for Tradename: HALOTHANE

« Back to Dashboard
Halothane is a drug marketed by BH, Halocarbon, and Hospira. and is included in three NDAs.

The generic ingredient in HALOTHANE is halothane. There are four drug master file entries for this compound. Additional details are available on the halothane profile page.

Summary for Tradename: HALOTHANE


Clinical Trials for: HALOTHANE

Vasodilation Effect of Inhalational Anesthetics
Status: Completed Condition: General Anesthesia

Desflurane and Its Effect on Postoperative Morbidity and Mortality in Patients Undergoing Thoracic Surgery
Status: Completed Condition: Thoracic Surgery

Emergence Agitation Between Sevoflurane and Desflurane in Pediatric
Status: Completed Condition: Children; Urologic Diseases; Ambulation Difficulty

Sevoflurane and Isoflurane - During Cardiopulmonary Bypass With the MECC System (Minimized Extracorporeal Circuit)
Status: Completed Condition: Myocardial Reperfusion Injury

Courtesy of
See more clinical trials for this drug
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Exclusivity Expiration
Liquid; Inhalation080810-001Approved prior to Jan 1, 1982RXNo<disabled><disabled>
Liquid; Inhalation083254-001Approved prior to Jan 1, 1982RXNo<disabled><disabled>
Liquid; Inhalation084977-001Approved prior to Jan 1, 1982RXNo<disabled><disabled>
This preview shows a limited data set
Subscribe for full access

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a free trial or see the database preview and plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn